Max Robotics — Global Service Robot Directory + US Certification

About

N. de Gregorio is a leading clinical researcher in gynecologic oncology, with a focused expertise in the diagnosis, staging, and prognosis of borderline ovarian tumors (BOT). Her major contributions center on refining surgical and biomarker-based strategies to improve patient outcomes. In her pivotal work as part of the AGO ROBOT study, de Gregorio conducted a subanalysis of 950 patients to evaluate the prognostic impact of individual surgical staging procedures for serous BOT. This research, cited 42 times, provides critical evidence that incomplete staging is a negative prognostic factor, guiding surgeons on the necessity of each specific step. Additionally, her investigation into the diagnostic value of serum CA125 in borderline tumors (14 citations) has helped clarify the limitations and appropriate use of this biomarker in a challenging diagnostic context. Through these studies, de Gregorio has advanced the standard of care for a patient population often managed with less aggressive disease, ensuring that surgical and diagnostic precision directly translates into better prognostic accuracy and tailored treatment.